{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:19:05Z","timestamp":1782523145824,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant disease caused by mutations in <jats:italic>APOE<\/jats:italic>, the gene which encodes apolipoprotein E. LPG mainly affects Asian individuals, however occasional cases have also been described in Americans and Europeans. Herein we report two unrelated Brazilian patients with LPG in whom genetic analyses revealed the APOE-Osaka\/Kurashiki variant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation - case 1<\/jats:title>\n                <jats:p>A 29-year-old Caucasian male sought medical attention with complaints of face swelling and foamy urine for the last 3 months. He denied a family history of kidney disease, consanguinity, or Asian ancestry. His tests showed proteinuria of\u00a012.5\u2009g\/24\u2009h, hematuria, serum creatinine 0.94\u2009mg\/dL, albumin 2.3\u2009g\/dl, total cholesterol 284\u2009mg\/dL, LDL 200\u2009mg\/dL, triglycerides 175\u2009mg\/dL, and negative screening for secondary causes of glomerulopathy. A kidney biopsy revealed intraluminal, laminated deposits of hyaline material in glomerular capillaries consistent with lipoprotein thrombi. These findings were confirmed by electron microscopy, establishing the diagnosis of LPG. His apolipoprotein E serum level was 72\u2009mg\/dL and genetic analysis revealed the <jats:italic>APOE<\/jats:italic> pathogenic variant c.527G\u2009&gt;\u2009C, p.Arg176Pro in heterozygosis, known as the Osaka\/Kurashiki mutation and positioned nearby the LDL receptor binding site.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case 2<\/jats:title>\n                <jats:p>A 34-year-old Caucasian man sought medical assessment for renal dysfunction and hypertension. He reported intermittent episodes of lower-limb edema for 3 years and a family history of kidney disease, but denied Asian ancestry. Laboratorial tests showed BUN 99\u2009mg\/dL, creatinine 10.7\u2009mg\/dL, total cholesterol 155\u2009mg\/dL, LDL 79\u2009mg\/dL, triglycerides 277\u2009mg\/dL, albumin 3.1\u2009g\/dL, proteinuria 2.7\u2009g\/24\u2009h, and negative screening for secondary causes of glomerulopathy. His kidney biopsy was consistent with advanced chronic nephropathy secondary to LPG. A genetic analysis also revealed the Osaka\/Kurashiki variant. He was transplanted a year ago, displaying no signs of disease relapse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We report two unrelated cases of Brazilian patients with a diagnosis of lipoprotein glomerulopathy whose genetic assessment identified the <jats:italic>APOE<\/jats:italic>-Osaka\/Kurashiki pathogenic variant, previously only described in eastern Asians. While this is the second report of LPG in Latin America, the identification of two unrelated cases by our medical team raises the possibility that LPG may be less rare in this part of the world than currently thought, and should definitely be considered when nephrotic syndrome is associated with suggestive kidney biopsy findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-021-01119-x","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T13:02:58Z","timestamp":1627304578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lipoprotein glomerulopathy associated with the Osaka\/Kurashiki APOE variant: two cases identified in Latin America"],"prefix":"10.1186","volume":"16","author":[{"given":"Joaquim Nelito","family":"da Silveira-Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Jinson","family":"de Oliveira Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precil Diego Miranda","family":"de Menezes Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius Augusto Ferreira","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"de Almeida Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Campos","family":"Wanderley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9ia","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elieser Hitoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neide Missae","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eny Maria Goloni","family":"Bertollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo Merege","family":"Vieira-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Ricardo","family":"de Ant\u00f4nio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Silva","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alice Sperto Ferreira","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Moys\u00e9s-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Fernando","family":"Onuchic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"issue":"2","key":"1119_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.kint.2019.10.031","volume":"97","author":"T Saito","year":"2020","unstructured":"Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E. Apolipoprotein E-related glomerular disorders. Kidney Int. 2020;97(2):279\u201388. https:\/\/doi.org\/10.1016\/j.kint.2019.10.031.","journal-title":"Kidney Int"},{"issue":"1","key":"1119_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5935\/0101-2800.20140015","volume":"36","author":"KL Pegas","year":"2014","unstructured":"Pegas KL, Rohde R, Garcia CD, Bittencourt Vde B, Keitel E, Poloni JA, et al. Lipoprotein glomerulopathy: a case report of a rare disease in a Brazilian child. J Bras Nefrol. 2014;36(1):93\u20135. https:\/\/doi.org\/10.5935\/0101-2800.20140015.","journal-title":"J Bras Nefrol"},{"issue":"24","key":"1119_CR3","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMc072088","volume":"357","author":"BH Rovin","year":"2007","unstructured":"Rovin BH, Roncone D, McKinley A, Nadasdy T, Korbet SM, Schwartz MM. APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy. N Engl J Med. 2007;357(24):2522\u20134. https:\/\/doi.org\/10.1056\/NEJMc072088.","journal-title":"N Engl J Med"},{"issue":"10","key":"1119_CR4","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/ndt\/gfq389","volume":"25","author":"AS Bomback","year":"2010","unstructured":"Bomback AS, Song H, D'Agati VD, Cohen SD, Neal A, Appel GB, et al. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy. Nephrol Dial Transplant. 2010;25(10):3442\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfq389.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1119_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1590\/2175-8239-jbn-2018-0148","volume":"41","author":"E Cambruzzi","year":"2019","unstructured":"Cambruzzi E, Pegas KL. Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: a review. J Bras Nefrol. 2019;41(3):393\u20139. https:\/\/doi.org\/10.1590\/2175-8239-jbn-2018-0148.","journal-title":"J Bras Nefrol"},{"issue":"5","key":"1119_CR6","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1681\/ASN.V85820","volume":"8","author":"S Oikawa","year":"1997","unstructured":"Oikawa S, Matsunaga A, Saito T, Sato H, Seki T, Hoshi K, et al. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol. 1997;8(5):820\u20133. https:\/\/doi.org\/10.1681\/ASN.V85820.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1119_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","volume":"56","author":"A Matsunaga","year":"1999","unstructured":"Matsunaga A, Sasaki J, Komatsu T, Kanatsu K, Tsuji E, Moriyama K, et al. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int. 1999;56(2):421\u20137. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00572.x.","journal-title":"Kidney Int"},{"issue":"6","key":"1119_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5551\/jat.7377","volume":"18","author":"A Mitani","year":"2011","unstructured":"Mitani A, Ishigami M, Watase K, Minakata T, Yamamura T. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 pro), in a dyslipidemic patient with lipoprotein glomerulopathy. J Atheroscler Thromb. 2011;18(6):531\u20135. https:\/\/doi.org\/10.5551\/jat.7377.","journal-title":"J Atheroscler Thromb"},{"issue":"6","key":"1119_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5551\/jat.8102","volume":"18","author":"T Tokura","year":"2011","unstructured":"Tokura T, Itano S, Kobayashi S, Kuwabara A, Fujimoto S, Horike H, et al. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy. J Atheroscler Thromb. 2011;18(6):536\u201341. https:\/\/doi.org\/10.5551\/jat.8102.","journal-title":"J Atheroscler Thromb"},{"issue":"8","key":"1119_CR10","doi-asserted-by":"publisher","first-page":"e1281","DOI":"10.1002\/mgg3.1281","volume":"8","author":"M Yang","year":"2020","unstructured":"Yang M, Weng Q, Pan X, Hussain HMJ, Yu S, Xu J, et al. Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations. Mol Genet Genomic Med. 2020 Aug;8(8):e1281. https:\/\/doi.org\/10.1002\/mgg3.1281.","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"1119_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3760\/cma.j.issn.1003-9406.2020.02.017","volume":"37","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wu H, Hu Z. Discovery of a Chinese Tibetan patient with lipoprotein glomerulopathy due to APOE Osaka\/Kurashiki variant. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020;37(2):166\u20139. https:\/\/doi.org\/10.3760\/cma.j.issn.1003-9406.2020.02.017.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"5","key":"1119_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"3","key":"1119_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1053\/j.ajkd.2005.12.031","volume":"47","author":"R Sam","year":"2006","unstructured":"Sam R, Wu H, Yue L, Mazzone T, Schwartz MM, Arruda JAL, et al. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding. Am J Kidney Dis. 2006;47(3):530\u201348.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1119_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1194\/jlr.M030965","volume":"54","author":"D Georgiadou","year":"2013","unstructured":"Georgiadou D, Stamatakis K, Efthimiadou EK, Kordas G, Gantz D. Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy. J Lipid Res. 2013;54(1):164\u201376. https:\/\/doi.org\/10.1194\/jlr.M030965.","journal-title":"J Lipid Res"},{"issue":"12","key":"1119_CR15","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1194\/jlr.M088732","volume":"59","author":"M Katsarou","year":"2018","unstructured":"Katsarou M, Stratikos E, Chroni A. Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy. J Lipid Res. 2018;59(12):2339\u201348. https:\/\/doi.org\/10.1194\/jlr.M088732.","journal-title":"J Lipid Res"},{"issue":"6","key":"1119_CR16","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1053\/j.ajkd.2004.08.048","volume":"45","author":"K Foster","year":"2005","unstructured":"Foster K, Matsunaga A, Matalon R, Saito T, Gallo G, D'Agati V, et al. A rare cause of posttransplantation nephrotic syndrome. Am J Kidney Dis. 2005;45(6):1132\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2004.08.048.","journal-title":"Am J Kidney Dis"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01119-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01119-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01119-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T13:03:47Z","timestamp":1627304627000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01119-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1119"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01119-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,26]]},"assertion":[{"value":"29 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from both patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}